MetLife stock momentum: a call spread risk reversal strategy

MetLife (MET) is well-positioned in the life insurance and benefits sector, exhibiting fundamental momentum that the broader market hasn't fully priced in. Backed by scale, brand equity, and an experienced leadership team, the company is firing on all cylinders. The stock's earnings yield relative to the 10-year Treasury yield—a key input in the Fed Model—remains attractive, suggesting that MET is not overvalued despite its recent run. With a forward P/E in the low-to-mid single digits, well below the S&P 500's average, the valuation gap provides a cushion. Additionally, breadth indicators show that the insurance sector is gaining relative strength, and sector rotation out of high-growth tech into value-oriented financials has supported MET. The company's robust buyback yield, currently around 5%, further enhances shareholder returns and underpins earnings per share growth.

Given MetLife's strong fundamental tailwinds and a clear path to earnings per share upside, a September 77.5/87.5/92.5 call spread risk reversal is structured to either capture further upside or potentially purchase the stock close to its long-term average around $78. This options strategy allows investors to participate in MetLife's upward momentum while mitigating immediate downside risk after the stock's impressive recent rally, and also reduces the impact of time decay (theta). The use of a call spread limits upside but also caps cost, while the risk reversal component (selling a put to finance the call spread) lowers the net premium outlay. For equities traders, such structured plays can be monitored on NowPrice's live options dashboard to track implied volatility and position Greeks. Implied volatility for MET options remains moderate, suggesting that the market is not pricing in extreme moves, which makes this strategy particularly attractive for capturing gradual upside.

Looking ahead, key factors to watch include MetLife's next earnings report, interest rate movements that affect the insurance sector's investment income, and any shifts in the broader market's risk appetite. The September expiration provides a defined timeframe for the thesis to play out, with the 77.5/87.5/92.5 strikes offering a balanced risk-reward profile. Should the stock rally above $92.50, the maximum gain is capped, but if it stays above $77.50, the strategy profits from time decay and price appreciation. Conversely, if the stock falls below $77.50, the investor may be assigned the stock at a net cost near the long-term average, providing a value entry. Monitoring the VIX and sector-specific implied volatility can help assess whether the strategy's risk profile remains favorable.